面向药物化学家和制药业的用户友好型工业集成人工智能

{"title":"面向药物化学家和制药业的用户友好型工业集成人工智能","authors":"","doi":"10.1016/j.aichem.2024.100072","DOIUrl":null,"url":null,"abstract":"<div><p>Artificial intelligence has brought crucial changes to the whole field of natural sciences. Myriads of machine learning algorithms have been developed to facilitate the work of experimental scientists. Molecular property prediction and drug synthesis planning become routine tasks. Moreover, inverse design of compounds with tunable properties as well as on-the-fly autonomous process optimization and chemical space exploration became possible <em>in silico</em>. Affordable robotic platforms exist able to perform thousands of experiments every day, analyzing the results and tuning the protocols. Despite this, most of these developments get trapped at the stage of code or overlooked, limiting their use by experimental scientists. Meanwhile, visibility and the number of user-friendly tools and technologies available to date is too low to compensate for this fact, rendering the development of novel therapeutic compounds inefficient. In this Review, we set the goal to bridge the gap between modern technologies and experimental scientists to improve drug development efficacy. Here we survey advanced and easy-to-use technologies able to help medical chemists at every stage of their research, including those integrated in technological processes during COVID-19 pandemic motivated by the need for fast yet precise solutions. Moreover, we review how these technologies are integrated by industry and clinics to streamline drug development and production. These technologies already transform the current paradigm of scientific thinking and revolutionize not only medicinal chemistry, but the whole field of natural sciences.</p></div>","PeriodicalId":72302,"journal":{"name":"Artificial intelligence chemistry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2949747724000307/pdfft?md5=6e0dd6833ec368337f7792d55171a0b8&pid=1-s2.0-S2949747724000307-main.pdf","citationCount":"0","resultStr":"{\"title\":\"User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals\",\"authors\":\"\",\"doi\":\"10.1016/j.aichem.2024.100072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Artificial intelligence has brought crucial changes to the whole field of natural sciences. Myriads of machine learning algorithms have been developed to facilitate the work of experimental scientists. Molecular property prediction and drug synthesis planning become routine tasks. Moreover, inverse design of compounds with tunable properties as well as on-the-fly autonomous process optimization and chemical space exploration became possible <em>in silico</em>. Affordable robotic platforms exist able to perform thousands of experiments every day, analyzing the results and tuning the protocols. Despite this, most of these developments get trapped at the stage of code or overlooked, limiting their use by experimental scientists. Meanwhile, visibility and the number of user-friendly tools and technologies available to date is too low to compensate for this fact, rendering the development of novel therapeutic compounds inefficient. In this Review, we set the goal to bridge the gap between modern technologies and experimental scientists to improve drug development efficacy. Here we survey advanced and easy-to-use technologies able to help medical chemists at every stage of their research, including those integrated in technological processes during COVID-19 pandemic motivated by the need for fast yet precise solutions. Moreover, we review how these technologies are integrated by industry and clinics to streamline drug development and production. These technologies already transform the current paradigm of scientific thinking and revolutionize not only medicinal chemistry, but the whole field of natural sciences.</p></div>\",\"PeriodicalId\":72302,\"journal\":{\"name\":\"Artificial intelligence chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2949747724000307/pdfft?md5=6e0dd6833ec368337f7792d55171a0b8&pid=1-s2.0-S2949747724000307-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Artificial intelligence chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949747724000307\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Artificial intelligence chemistry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949747724000307","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

人工智能给整个自然科学领域带来了至关重要的变化。无数机器学习算法应运而生,为实验科学家的工作提供了便利。分子性质预测和药物合成规划已成为常规任务。此外,反向设计具有可调特性的化合物,以及实时自主优化工艺和探索化学空间,都已成为可能。经济实惠的机器人平台能够每天进行数千次实验,分析实验结果并调整实验方案。尽管如此,这些开发成果大多停留在代码阶段或被忽视,限制了实验科学家对它们的使用。与此同时,迄今为止可用的用户友好型工具和技术的知名度和数量太低,无法弥补这一事实,导致新型治疗化合物的开发效率低下。在这篇综述中,我们的目标是弥合现代技术与实验科学家之间的差距,提高药物开发的效率。在此,我们调查了能够在研究的每个阶段为医学化学家提供帮助的先进且易于使用的技术,包括在 COVID-19 大流行期间因需要快速而精确的解决方案而整合到技术流程中的技术。此外,我们还回顾了工业和诊所如何将这些技术整合到一起,以简化药物开发和生产过程。这些技术已经改变了当前的科学思维模式,不仅彻底改变了药物化学,而且改变了整个自然科学领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
User-friendly and industry-integrated AI for medicinal chemists and pharmaceuticals

Artificial intelligence has brought crucial changes to the whole field of natural sciences. Myriads of machine learning algorithms have been developed to facilitate the work of experimental scientists. Molecular property prediction and drug synthesis planning become routine tasks. Moreover, inverse design of compounds with tunable properties as well as on-the-fly autonomous process optimization and chemical space exploration became possible in silico. Affordable robotic platforms exist able to perform thousands of experiments every day, analyzing the results and tuning the protocols. Despite this, most of these developments get trapped at the stage of code or overlooked, limiting their use by experimental scientists. Meanwhile, visibility and the number of user-friendly tools and technologies available to date is too low to compensate for this fact, rendering the development of novel therapeutic compounds inefficient. In this Review, we set the goal to bridge the gap between modern technologies and experimental scientists to improve drug development efficacy. Here we survey advanced and easy-to-use technologies able to help medical chemists at every stage of their research, including those integrated in technological processes during COVID-19 pandemic motivated by the need for fast yet precise solutions. Moreover, we review how these technologies are integrated by industry and clinics to streamline drug development and production. These technologies already transform the current paradigm of scientific thinking and revolutionize not only medicinal chemistry, but the whole field of natural sciences.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Artificial intelligence chemistry
Artificial intelligence chemistry Chemistry (General)
自引率
0.00%
发文量
0
审稿时长
21 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信